GRS

TRANSLATE

MENU menu

Close close menu

GRS Blog

PAST POSTS menu

Close close menu

Europe: Academia and industry push for revisions to Clinical Trials Directive

27/9/2011

According to many UK/European academic and industry stakeholders, the EU's Clinical Trials Directive has "resulted in unnecessary complexity and bureaucracy that are hampering the progress of medical research by pushing up the time and costs needed to get clinical studies underway".  More...

 

Author: Greer Deal, Director of Global Regulatory Services (GRS)

Past Posts...

Stem Cells and Autism
18 September 2011